Rubiadin exerts an acute and chronic anti-inflammatory effect in rodents / A Rubiadina exerce um efeito anti-inflamatório agudo e crônico em roedores

Rubiadin is identified as a bioactive anthraquinone that exists in some quinone rich plants. The current research was carried out to evaluate the potential anti-inflammatory impact of Rubiadin in acute and chronic inflammation test models in rodents. The anti-inflammatory activity of Rubiadin was examined in cotton pellet-induced granuloma and carrageenan-induced edema as chronic and acute inflammation models in rats. TNF-α level and histopathological changes were assessed using sampled foot tissue of rat in the acute model. Also, the IL-1β level was assessed in the chronic model. One-way ANOVA (post hoc Tukey’s) analysis was used for comparing the groups. Rubiadin (0.5 mg/kg, i.p.) induced a significant reduction in TNF α level and the paw edema compared to the control group in carrageenan test. Also, it was observed that the anti-inflammatory activity of Rubiadin (0.5 mg/kg, i.p.) is comparable to mefenamic acid (30 mg/kg, i.p.) as the standard drug. Rubiadin was effective in granuloma induced by cotton pellet concerning the granuloma and transudate formation amount. Rubiadin's anti-inflammatory effects were associated with a significant IL-1β decrease in this model. The results suggest that Rubiadin as a natural compound can possess significant peripheral anti-inflammatory impacts.

A rubiadina é identificada como uma antraquinona bioativa que existe em algumas plantas ricas em quinonas. A presente pesquisa foi realizada para avaliar o potencial impacto anti-inflamatório da rubiadina em modelos de teste de inflamação aguda e crônica em roedores. A atividade anti-inflamatória da rubiadina foi examinada em granuloma induzido por pellet de algodão e edema induzido por carragenina como modelos de inflamação crônica e aguda em ratos. O nível de TNF-α e as alterações histopatológicas foram avaliados usando amostra de tecido do pé de rato no modelo agudo. Além disso, o nível de IL-1β foi avaliado no modelo crônico. A análise ANOVA de uma via (post hoc de Tukey) foi usada para comparar os grupos. A rubiadina (0,5 mg / kg, i.p.) induziu uma redução significativa no nível de TNF α e no edema da pata em comparação com o grupo de controle no teste de carragenina. Além disso, foi observado que a atividade anti-inflamatória da rubiadina (0,5 mg / kg, i.p.) é comparável ao ácido mefenâmico (30 mg/kg, i.p.) como o fármaco padrão. A rubiadina foi eficaz no granuloma induzido por pellet de algodão no que diz respeito à quantidade de granuloma e formação de transudato. Os efeitos anti-inflamatórios da rubiadina foram associados a uma redução significativa de IL-1β nesse modelo. Os resultados sugerem que a rubiadina como um composto natural pode ter impactos anti-inflamatórios periféricos significativos.

Bajos niveles de inhibidores de la coagulación: un factor de alto riesgo trombogénico en pacientes talasémicos / Low levels of coagulation inhibitors: a high-risk thrombotic factor in thalassemic patients

ANTECEDENTES Y OBJETIVO: La β-talasemia mayor (β-TM) se define como una enfermedad hereditaria relacionada con las células rojas sanguíneas. En los pacientes adultos, los eventos trombóticos se asocian con la talasemia. Así, el objetivo de esta investigación fue examinar algunos de los parámetros hemostáticos, incluyendo la antitrombina III (AT-III), la proteína C (PRC) y la proteína S (PRS), en pacientes β-TM. MÉTODOS: Se seleccionó a 30pacientes β-TM remitidos para un ingreso de seguimiento de rutina en la clínica de talasemia del Centro Especial de Enfermedades Kerman, junto con otros 30 sujetos sanos. Tras el registro y 3 semanas después de la última transfusión, se recogieron especímenes de sangre periférica, y se midió la concentración plasmática de AT-III, PRC y PRS. RESULTADOS: Hemos observado que la concentración de inhibidores naturales de la coagulación (PRC y PRS) estaba ligeramente disminuida en los pacientes β-TM (p < 0,05), mientras que el nivel plasmático de AT-III no era muy diferente en los pacientes β-TM cuando se los comparaba con los sujetos sanos. CONCLUSIÓN: Conforme a los hallazgos obtenidos en el presente trabajo, podríamos considerar los cambios significativos en las PRC, PRS y AT-III, que se observan en pacientes β-TM multitransfundidos, como factores de riesgo críticos para el desarrollo de eventos tromboembólicos futuros a lo largo de su vida

BACKGROUND AND AIM: The β-thalassemia major (β-TM) is defined as a hereditary red blood cell-related disease. Thrombotic events are associated with thalassemia in adult patients. Thus, the present investigation was aimed to examine some hemostatic parameters, including anti thrombin-III (AT-III), protein-C (PRC) and protein-S (PRS) in β-TM patients. METHODS: Thirty B-TM patients who referred for routine follow-up admission to the thalassemia clinic of Kerman Special Disease Center alongside with 30 healthy subjects were selected and enrolled in the present study. Further registration, the peripheral blood specimens were collected after 3 weeks of last transfusion and then the plasma concentrations of AT-III, PRC and PRS were measured in them. RESULTS: We have observed that the concentrations of natural coagulation inhibitors (PRC and PRS) were significantly attenuated in β-TM patients (P<0.05), while the plasma level of AT-III was not remarkably differed in β-TM patients in compare to healthy subjects. CONCLUSION: According to the findings of present work, significant changes in the PRC, PRS and AT-III which could be observed in multi transfused β-TM patients may attribute as critical risk factors for the development of upcoming thromboembolic events in their future life

Low levels of coagulation inhibitors: A high-risk thrombotic factor in thalassemic patients. / Bajos niveles de inhibidores de la coagulación: un factor de alto riesgo trombogénico en pacientes talasémicos.

BACKGROUND AND AIM: The ß-thalassemia major (ß-TM) is defined as a hereditary red blood cell-related disease. Thrombotic events are associated with thalassemia in adult patients. Thus, the present investigation was aimed to examine some hemostatic parameters, including anti thrombin-III (AT-III), protein-C (PRC) and protein-S (PRS) in ß-TM patients. METHODS: Thirty B-TM patients who referred for routine follow-up admission to the thalassemia clinic of Kerman Special Disease Center alongside with 30 healthy subjects were selected and enrolled in the present study. Further registration, the peripheral blood specimens were collected after 3 weeks of last transfusion and then the plasma concentrations of AT-III, PRC and PRS were measured in them. RESULTS: We have observed that the concentrations of natural coagulation inhibitors (PRC and PRS) were significantly attenuated in ß-TM patients (P<0.05), while the plasma level of AT-III was not remarkably differed in ß-TM patients in compare to healthy subjects. CONCLUSION: According to the findings of present work, significant changes in the PRC, PRS and AT-III which could be observed in multi transfused ß-TM patients may attribute as critical risk factors for the development of upcoming thromboembolic events in their future life.

Deep convolutional neural network for classification of sleep stages from single-channel EEG signals.

Using a smart method for automatic diagnosis in medical applications, such as sleep stage classification is considered as one of the important challenges of the last few years which can replace the time-consuming process of visual inspection done by specialists. One of the problems regarding the automatic diagnosis of sleep patterns is extraction and selection of discriminative features generally demanding high computational burden. This paper provides a new single-channel approach to automatic classification of sleep stages from EEG signal. The main idea is to directly apply the raw EEG signal to deep convolutional neural network, without involving feature extraction/selection, which is a challenging process in the previous literature. The proposed network architecture includes 9 convolutional layers followed by 2 fully connected layers. In order to make the samples of different classes balanced, we used a preprocessing method called data augmentation. The simulation results of the proposed method for classification of 2 to 6 classes of sleep stages show the accuracy of 98.10%, 96.86%, 93.11%, 92.95%, 93.55% and Cohen's Kappa coefficient of 0.98%, 0.94%, 0.90%, 0.86% and 0.89%, respectively. Furthermore, comparing the obtained results with the state-of-the-art methods reveals the performance improvement of the proposed sleep stage classification in terms of accuracy and Cohen's Kappa coefficient.

An appraisal of moulting on post-moult egg production and egg weight distribution in white layer hens; meta-analysis.

1. The aim of this study was to establish how different moulting methods and body weight losses influenced post-moult performance and USDA egg weight distribution. 2. Data on 5 laying flocks (#34-38) of the North Carolina Layer Performance and Management Test were used in this meta-analysis. 3. The moulting methods were non-fasted moulted (NF), short feed restricted (SF), 13-d feed restricted (FR), non-anorexic moult programme (NA), non-anorexic moult programme with low sodium (NALS) as well as non-moulting programme as control treatment. The percentages of targeted body weight loss during the moulting period were 20, 24, 25 and 30% of body weight at the end of the first egg production cycle. 4. Post-moult egg production and egg mass were influenced by all moulting methods. Maximum increase in post-moult egg production rate and egg mass occurred with FR and NF programmes, respectively, at 30% of body weight loss, compared to non-moulted hens. Non-fasting methods reduced mortality rate more effectively than fasting methods. 5. Moulting resulted in increases in percentage of grade A and decreases in percentage of grade B eggs. Non-fasting methods increased percentage of grade A eggs more effectively than fasting methods. Percentage of cracked eggs decreased in moulted rather than non-moulted hens and the lowest rate was associated with the NA programme. 6. Post-moult egg weight was not significantly influenced by moulting methods. However, percentage of body weight reduction affected egg weight. The optimum increment in egg weight was achieved by 24% body weight reduction. 7. Overall, non-fasting methods resulted in similar egg production compared with fasting methods. Considering post-moult mortality and USDA egg weight distribution, non-fasting methods, especially NF and NA programmes, performed much better than fasting methods, indicating that non-fasting moulting methods, which are better for animal welfare, are effective alternatives to fasting methods.

Effects of short-term metformin therapy associated with levothyroxine dose decrement on TSH and thyroid hormone levels in patients with thyroid cancer.

AIM: Suppressive therapy with levothyroxine is the main step in treatment of differentiated thyroid cancer (DTC). However, subclinical hyperthyroidism is associated with deleterious effects on cardiovascular and skeletal systems. Metformin may have a suppressive effect on TSH level. METHODS: We performed a single blind randomized controlled trial on the effect of short term Metformin therapy on 50 non-diabetic patients with DTC (mean age of 39.68 ±8.7 years) under suppressive therapy with levothyroxine. Metformin (500 mg) or placebo was added to the drug regimen of the patients and levothyroxine dose decreased by 33%. TSH and thyroid hormone values were measured at the beginning of the study and 3 months after treatment. RESULTS: Forty-six patients had papillary and 4 had follicular carcinoma. The mean dose of levothyroxine was 2.2±0.48 µg/kg. The mean TSH level at the beginning of the study was 0.05±.04 mIU/L. The mean age, weight and baseline TSH level was not significantly different between metformin and placebo groups (P>0.2). In the metformin group, the mean (±SD) TSH level was significantly increased from 0.03±0.04 to 3.1±5.7 mIU/L after 3 months of intervention (P=0.01) and the mean thyroid hormone levels were significantly decreased (P<0.001). In the placebo group, the mean TSH level increased from 0.04±0.04 to 3.1±4.7 mIU/L after 3 months (P=0.003). Delta TSH was 3.0±5.6 mIU/L and 3.1±4.7 mIU/L in metformin and placebo groups, respectively (P=0.9). CONCLUSION: Adding 500 mg of metformin to drug regimen was not useful to compensate for 33% of levothyroxine dose reduction in patients with DTC.

Particle stability in dilute fermented dairy drinks: formation of fluid gel and impact on rheological properties.

Fluid gels are known to be very shear-thinning materials with yield stress. In this study, the rheological properties of gellan and gellan-pectin fluid gels in fermented dairy drinks were evaluated using viscometric measurements. Both gellan- and gellan-pectin-containing solutions showed the rheological properties of fluid gels resulting in stabilization of particles; but no evidence of a fluid gel was observed for those with pectin alone and those with no hydrocolloid content. Unlike pectin, gellan gum was capable of creating significant values of yield stress and accordingly stabilized colloidal particles and extrinsic added solid particles in the fermented dairy drink. However, pectin improved the stability in combination with gellan. The origin of fluid gel formation was assumed to be both permanent interactions occurring between gellan and proteins, forming hairy particle gels and transient interactions between the particle gels. The significance of yield stress values for particle stability was demonstrated and two methods, including a noteworthy infinite apparent viscosity method and a conventional Bingham approach, were employed to calculate the values of yield stress. Both the methods showed a good application potential due to their simplicity, reasonable results and also wide availability of the instrument applied.

Outbreak of severe disseminated aspergillosis in a flock of ostrich (Struthio camelus).

This study was undertaken to describe clinical, mycological and histopathological findings in black neck ostriches affected with severe aspergillosis in a flock including 80 birds, near Tehran, Iran. The signs included anorexia, depression, notable weight loss, diarrhoea, severe respiratory distress and death. Grossly, the lungs showed numerous white to yellow caseous nodules and the walls of the thoracic and abdominal air sacs were thickened with inflammatory exudates containing cellular debris, necrotic masses and green mold colonies. Multiple nodules were observed in the liver, spleen and gastrointestinal tract as well. Histopathologically, there were conidial heads and fungal hyphae in the air sacs and multifocal necrotic and granulomatous lesions with septated and dichotomously branched hyphae in various tissues, which were stained with haematoxylin and eosin and Grocott's methenamine silver nitrate. Aspergillus fumigatus was isolated in various tissues taken from affected ostriches.

Hashimoto's thyroiditis presenting as single hot nodule and hypothyroidism.

Radionuclide thyroid scanning of patients with Hashimoto's thyroiditis (HT) may mimic other thyroid disorders including cold nodules, multinodular goiter and rarely hot nodules. The association of single hot nodules in such patients in the face of primary hypothyroidism has not been previously reported. We describe 6 female patients with HT who presented either with symptoms of overt thyroid failure or a sensation of lump in the neck (and later found to have mild thyroid failure) who had single firm thyroid nodules. These nodules were hot by both 99mTc pertechnetate and radioiodine thyroid scans. In three of 4 patients followed up for longer than 6 months on adequate thyroid replacement therapy the nodules regressed by up to 60%. Given "Best practice" recommendations patients with thyroid failure and single thyroid nodules would not be submitted to radionuclide scanning and this presentation of HT would have gone undetected.